Lexeo Therapeutics Inc (LXEO)

Stock-Based Compensation

$5.69M

Quarterly · Period ending: · USD

LXEO logo

LXEO Stock-Based Compensation

Latest reported$5.69M
LXEO Quarterly Stock-Based Comp ($0.00 → $5.69M)
High-resolution chart · PNG

LXEO stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Lexeo Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
5,690,000
2,755,000
2,713,000
2,651,000
3,071,000
3,697,000
3,507,000
3,790,000
2,846,000
2,331,000
804,000
873,000
0
397,000
521,000
431,000
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.